Talphera, Inc. (TLPH) stock
Close on Nov 11, 2026Market cap $54.50MP/E –Yield –
Talphera, Inc. saw revenue fall 96.3% to $1.00K over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $54.50M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $54.50M
- P/E ratio
- –
- Price to sales
- 54501.10
- Price to book
- 3.78
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.00K
- Net income
- -$15.08M
- EPS, diluted
- -$0.27
- Book value per share
- $0.19
- Diluted shares
- 76M
Trading
- Next earnings
- Nov 11, 2026 (estimated, during market hours)
- Previous close
- $1.05
- Open
- $1.08
- Day's range
- $1.03 – $1.08
- Volume
- 186,256
- Average volume (20 days)
- 82,108
- Beta (5 years)
- 0.64
- 52-week range
- $0.69 – $1.57
- RSI (14 days)
- 45.5
- Volatility (1 year)
- 71.3%
- Relative volume
- 0.85×
- WACC
- 8.1%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | TLPH | S&P 500 | Difference | TLPH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.8% | -2.4% | −0.4 pts | ||
| 3 months | -28.6% | -1.2% | −27.4 pts | ||
| Year to date | -7.9% | +12.3% | −20.2 pts | ||
| 1 year | -18.6% | +12.4% | −31.1 pts | ||
| 3 years | +126.8% | +78.8% | +48.0 pts | +31.4% | +21.4% |
| 5 years | -93.4% | +75.2% | −168.6 pts | -42.0% | +11.9% |
| 10 years | -98.4% | +311.1% | −409.5 pts | -33.8% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Talphera filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateResults
- Results
- Results
- Results
About Talphera
Pharmaceutical Preparations
The company is a specialty pharmaceutical business dedicated to developing and commercializing therapies for medically supervised healthcare settings. Its lead pipeline product is Niyad, a regional anticoagulant formulated with nafamostat for infusion into extracorporeal circuits during continuous renal replacement therapy. The enterprise is also investigating LTX-608, a direct intravenous nafamostat formulation targeting conditions such as disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and viral infections. Intended customers and end users include hospital intensive care units, dialysis centers, and specialized clinical care providers.
Company profile, executives and historyTalphera stock: common questions
What is Talphera's stock price?
TLPH closed at $1.05 on Nov 11, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $0.69 and $1.57.
What is Talphera's market cap?
Talphera was worth $54.50M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is TLPH's P/E ratio?
Talphera lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.27), so it has no meaningful P/E ratio.
How much revenue does Talphera make?
Talphera reported revenue of $1.00K for the twelve months to Jun 30, 2026, down 96.3% from a year earlier.
Does Talphera pay a dividend?
No. Talphera has not paid a cash dividend over the last twelve months.
When does Talphera report earnings next?
Talphera is expected to report Q3 FY2026 results on Nov 11, 2026, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has TLPH stock performed over the past year?
Including dividends, TLPH returned -18.6% over the past year, against +12.4% for the S&P 500.
How many TLPH shares are sold short?
1M shares were sold short at the latest FINRA report, 4.41% of the float, or 27.7 days of average trading volume.
Who are Talphera's competitors?
Companies most similar to Talphera by business, industry and size include TCRT, BCDA, KPRX, AZTR, PRFX.
See a number that looks wrong?